Booz Allen Hamilton Holding Corporation (BAH) Insider Trading

Last 12 months

Insiders bought $2.01M and sold $64k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan.

Net open-market

+$1.95M

1 buy · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 1

executives and directors

Last open-market buy

Oct 2025

Oct 30, 2025

Get an email when BAH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 13	Dennis Metzfield VP, PAO & Controller	SoldNo plan	469	$77.92	$37k	8.6%	Form 4
Feb 26	Dennis Metzfield VP, PAO & Controller	SoldNo plan	350	$78.59	$28k	8.1%	Form 4
Oct 30, 2025	Horacio Rozanski President and CEO	Bought	23,800	$84.66	$2.01M	3.6%	Form 4
Feb 5, 2025	Joan Lordi Amble Director	Bought	930	$130.90	$122k	1.7%	Form 4
Dec 6, 2024	Joan Lordi Amble Director	Bought	690	$145.66	$101k	1.2%	Form 4
Nov 22, 2024	Joan Lordi Amble Director	Bought	2,000	$147.13	$294k	3.8%	Form 4
Oct 25, 2024	Nancy Laben EVP & Chief Legal Officer	Sold10b5-1 plan	11,984	$180.96	$2.17M	33%	Form 4
Oct 24, 2024	Richard Crowe Executive Vice President	Sold10b5-1 plan	4,243	$165.00	$700k	14%	Form 4
Oct 24, 2024	Matthew Calderone EVP & Chief Financial Officer	Sold10b5-1 plan	4,065	$165.00	$671k	12%	Form 4

Aug 13No plan
Dennis Metzfield
VP, PAO & Controller · sold 469 at $77.92
$37k
8.6% of stake
Feb 26No plan
Dennis Metzfield
VP, PAO & Controller · sold 350 at $78.59
$28k
8.1% of stake
Oct 30, 2025
Horacio Rozanski
President and CEO · bought 23,800 at $84.66
$2.01M
3.6% of stake
Feb 5, 2025
Joan Lordi Amble
Director · bought 930 at $130.90
$122k
1.7% of stake
Dec 6, 2024
Joan Lordi Amble
Director · bought 690 at $145.66
$101k
1.2% of stake
Nov 22, 2024
Joan Lordi Amble
Director · bought 2,000 at $147.13
$294k
3.8% of stake
Oct 25, 202410b5-1 plan
Nancy Laben
EVP & Chief Legal Officer · sold 11,984 at $180.96
$2.17M
33% of stake
Oct 24, 202410b5-1 plan
Richard Crowe
Executive Vice President · sold 4,243 at $165.00
$700k
14% of stake
Oct 24, 202410b5-1 plan
Matthew Calderone
EVP & Chief Financial Officer · sold 4,065 at $165.00
$671k
12% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BAH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Management Consulting Services

GGenpact Ltd.

FCNFti Consulting Inc.

ASTHAstrana Health Inc.

ICFIICF International Inc.

HURNHuron Consulting Group Inc.

ITGartner Inc.

VVXV2X Inc.

EVHEvolent Health Inc.

Spot a number that looks wrong? Check it in BAH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BAH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.